Mortality and cancer incidence in males with Y polysomy in Britain: A cohort study
Mortality and cancer incidence in males with Y polysomy in Britain: A cohort study
The mortality and cancer incidence risks among males with Y polysomy are unknown because there have been no large long-term cohort studies carried out of such men. We conducted a cohort study of 667 men diagnosed with the abnormality in Britain since 1959 to compare their mortality and cancer incidence rates with those of the general population. Sixty deaths occurred during follow-up to December 2005, twice the number expected from general population rates (standardised mortality ratio (SMR) = 2.0 (95% confidence interval (CI) 1.5-2.6)). Significantly raised mortality was observed for diseases of the nervous system (SMR = 7.0, 95% CI: 2.3-16.4), circulatory system (SMR = 2.1, 95% CI: 1.3-3.2), respiratory system (SMR = 4.0, 95% CI: 1.8-7.5), genitourinary system (SMR = 10.2, 95% CI: 1.2-36.9), and congenital anomalies (SMR = 11.9, 95% CI: 3.2-30.5). Four of the five nervous system deaths were from epilepsy, the risk of death from this condition being more than 20-fold raised. The rates of cancer incidence and mortality among these men was not significantly different from those in the general population. This study provides evidence that mortality rates from several specific causes are raised among men with Y polysomy. The use of these data in genetic counselling should be cautious particularly for cases of Y polysomy that are detected prenatally. Further investigations are required to confirm these findings and to elucidate the possible role of genes on the Y chromosome in the aetiology of these causes of death.
great britain, humans, britain, genes, mortality, cancer, epilepsy, male, research, role, population, incidence, cardiovascular diseases, disease, chromosomes, human
691-696
Higgins, Craig D.
93df71b7-f76b-4b16-9a5b-359ae84377d2
Swerdlow, Anthony J.
5f6c764b-1374-49d1-bcee-1bdae5f47b9d
Schoemaker, Minouk J.
d6949f41-d64c-4b46-aedb-d6a87c36797f
Wright, Alan F.
7efbb151-a98c-4398-b69f-92d5cac84f50
Jacobs, Patricia A.
fe154474-b578-4a6b-ba4a-7f3fdbc80dc5
and On behalf of the UK clinical cytogenetics group, None
b5994651-f51f-4a4c-afad-1f2d61cb9e68
July 2007
Higgins, Craig D.
93df71b7-f76b-4b16-9a5b-359ae84377d2
Swerdlow, Anthony J.
5f6c764b-1374-49d1-bcee-1bdae5f47b9d
Schoemaker, Minouk J.
d6949f41-d64c-4b46-aedb-d6a87c36797f
Wright, Alan F.
7efbb151-a98c-4398-b69f-92d5cac84f50
Jacobs, Patricia A.
fe154474-b578-4a6b-ba4a-7f3fdbc80dc5
and On behalf of the UK clinical cytogenetics group, None
b5994651-f51f-4a4c-afad-1f2d61cb9e68
Higgins, Craig D., Swerdlow, Anthony J., Schoemaker, Minouk J., Wright, Alan F., Jacobs, Patricia A. and and On behalf of the UK clinical cytogenetics group, None
(2007)
Mortality and cancer incidence in males with Y polysomy in Britain: A cohort study.
Human Genetics, 121 (6), .
(doi:10.1007/s00439-007-0365-8).
Abstract
The mortality and cancer incidence risks among males with Y polysomy are unknown because there have been no large long-term cohort studies carried out of such men. We conducted a cohort study of 667 men diagnosed with the abnormality in Britain since 1959 to compare their mortality and cancer incidence rates with those of the general population. Sixty deaths occurred during follow-up to December 2005, twice the number expected from general population rates (standardised mortality ratio (SMR) = 2.0 (95% confidence interval (CI) 1.5-2.6)). Significantly raised mortality was observed for diseases of the nervous system (SMR = 7.0, 95% CI: 2.3-16.4), circulatory system (SMR = 2.1, 95% CI: 1.3-3.2), respiratory system (SMR = 4.0, 95% CI: 1.8-7.5), genitourinary system (SMR = 10.2, 95% CI: 1.2-36.9), and congenital anomalies (SMR = 11.9, 95% CI: 3.2-30.5). Four of the five nervous system deaths were from epilepsy, the risk of death from this condition being more than 20-fold raised. The rates of cancer incidence and mortality among these men was not significantly different from those in the general population. This study provides evidence that mortality rates from several specific causes are raised among men with Y polysomy. The use of these data in genetic counselling should be cautious particularly for cases of Y polysomy that are detected prenatally. Further investigations are required to confirm these findings and to elucidate the possible role of genes on the Y chromosome in the aetiology of these causes of death.
This record has no associated files available for download.
More information
Published date: July 2007
Keywords:
great britain, humans, britain, genes, mortality, cancer, epilepsy, male, research, role, population, incidence, cardiovascular diseases, disease, chromosomes, human
Identifiers
Local EPrints ID: 59824
URI: http://eprints.soton.ac.uk/id/eprint/59824
ISSN: 0340-6717
PURE UUID: 179f167f-265b-420b-b2c8-2fd888f33430
Catalogue record
Date deposited: 05 Sep 2008
Last modified: 15 Mar 2024 11:17
Export record
Altmetrics
Contributors
Author:
Craig D. Higgins
Author:
Anthony J. Swerdlow
Author:
Minouk J. Schoemaker
Author:
Alan F. Wright
Author:
Patricia A. Jacobs
Author:
None and On behalf of the UK clinical cytogenetics group
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics